Patent details
EP2332575 Title: Treatment of cancer with novel anti-IL 13 monoclonal antibodies
Basic Information
- Publication number:
- EP2332575
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP101797751
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Treatment of cancer with novel anti-IL 13 monoclonal antibodies
- French Title of Invention:
- Traitement du cancer au moyen de nouveaux anticorps monoclonaux anti-IL 13
- German Title of Invention:
- Behandlung von Krebs mit neuen monoklonalen anti-IL-13-Antikörpern
- SPC Number:
Dates
- Filing date:
- 23/12/2004
- Grant date:
- 12/11/2014
- EP Publication Date:
- 12/11/2014
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/06/2011
- EP B1 Publication Date:
- 12/11/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 23/12/2014
- Expiration date:
- 23/12/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 23/12/2004
- Name:
- Genentech Inc.
- Address:
- 1 DNA Way, South San Francisco, CA 94080, United States (US)
Inventor
1
- Name:
- Fung Sek Chung
- Address:
- United States (US)
2
- Name:
- Moyle Matthew
- Address:
- United States (US)
Priority
- Priority Number:
- 532130 P
- Priority Date:
- 23/12/2003
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 39/395;
| Filing date | Document type | Number of pages |
|---|